1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow CTX001: new trials by email Literature Review of CTX001 trials Research Report on CTX001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease Placebo, CTX001, Ferrous Sulfate - Chronic Kidney Disease, Anemia | Phase 1 | Not yet recruiting | Cajal Therapeutics Inc. | 24 | 2026-11-01 | 2026-10-28 |
| An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA) CTx001 - Geographic Atrophy Secondary to Age-related Macular Degeneration | Phase 1 / Phase 2 | Recruiting | Complement Therapeutics | 75 | 2025-12-30 | 2026-10-16 |
Anemia (1) · Renal Insufficiency, Chronic (1)
Cajal Therapeutics Inc. (1) · Complement Therapeutics (1)
Australia (1) · United Kingdom (1) · United States (1)